Clinical Observation of Cefixime Combined with Montmorillonite Powder in Treating Pediatric Bacterial Enteritis

Objective: To evaluate the clinical efficacy of cefixime (Cef) combined with montmorillonite powder (MP) in treating pediatric bacterial enteritis. Methods: Seventy-two cases of bacterial enteritis in children admitted between October 2021 and October 2023 were selected and randomly divided into two groups. The combination group received Cef treatment alongside MP, while the control group received only Cef treatment. The groups were compared based on overall efficacy, symptom relief time, and other indicators. Results: The combination group showed a higher overall efficacy, shorter symptom relief time, lower levels of inflammatory markers post-treatment, and a higher proportion of normal and grade I dysbiosis in the intestinal flora, with significant differences compared to the control group (P < 0.05). Conclusion: Cef combined with MP is significantly effective in treating pediatric bacterial enteritis, promoting symptom relief, reducing inflammation, and correcting intestinal flora imbalance.